⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Prasad ShirvalkarMD, PHD

Neurology · New York, NY 10065

NPI: 1447526462

Share:

38

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

276

Total Claims

$29K

Drug Cost

34

Beneficiaries

$863

Cost/Patient

Risk Score Breakdown 38/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Opioid rate (national percentile)+5

Score components are additive. Read full methodology

Peer Comparison vs. 13,194 Neurology providers

+3391%

Opioid rate vs peers

45.7% vs 1.3% avg

-79%

Cost per patient vs peers

$863 vs $4,034 avg

+58%

Brand preference vs peers

14.9% vs 9.4% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 3,391% above the average for Neurology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

45.7%

Opioid Rate

126

Opioid Claims

$14K

Opioid Cost

38.1%

Long-Acting Rate

This provider's opioid prescribing rate of 45.7% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

85% generic

Brand: 41 claims · $18K

Generic: 235 claims · $11K

Patient Profile

69

Avg Age

62%

Female

1.54

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About